崇尚科学, 也有点迷信分享 http://blog.sciencenet.cn/u/gaojianguo

博文

重视应用“三药三方”抗击COVID-19

已有 6912 次阅读 2020-10-3 13:04 |系统分类:科普集锦

Importance of Traditional Chinese Medicine in combating COVID-19


Writer’s note: It’s a manuscript that was written on 1st June. Since we have developed the vaccines successfully (which is outrun of experts’ previous expectations), there is no need to publish it in an official journal. But, I still believe that traditional Chinese medicine is a powerful cure in combating unknown viruses or diseases, such as COVID-69. The readers may find it’s interesting to read my science fiction: COVID-69: https://socialsciences.nature.com/posts/covid-69-science-fiction

   

traditional-chinese-3666268_1920.jpg

Image credit: iStock.


Since the global pandemic of coronavirus disease (COVID-19) in 2019, more than 6.2 million people have been infected and more than 360,000 people have died from the disease. Currently, at least 60 drug companies and universities worldwide are working overtime to develop vaccines and drugs to treat COVID-19. However, the predicted time for vaccine development is from a year to 18 months as indicated by a molecular virologist Peter Hotez (1). Therefore, owing to the inherent long duration required for vaccine development and subsequent time-consuming clinical trials (2), modern medical technology is proving insufficient to treat patients (3). This implies that COVID-19 will continue to pose a serious disease burden and a threat to life. Here, I suggest that all countries, governments, and medical institutions should emphasize the treatment of COVID-19 with traditional Chinese medicine (TCM) (4, 5), especially "Three Medicines & Three Formulas" (3M3F), which are mainly based on the below mentioned three practical considerations.


(1) 3M3F have been proven to have good and safe therapeutic effects and have almost no adverse side effects. In contrast, some clinical drugs used to treat COVID-19 have been shown to significantly increase arrhythmia and sudden cardiac death risk (6). Statistics from the World Health Organization (WHO) show that approximately 6% to 10% of patients with mild COVID-19, who did not receive any treatment, developed a severe form of the disease; however, at the Jiangxia Hospital of Wuhan, patients who received the 3M3F treatment did not show progression to severe disease. A National Administration of Traditional Chinese Medicine report shows that of the 1,261 patients with COVID-19 in 10 Chinese provinces who were administered the "Lung Cleaning and Detoxifying Decoction," 1,102 were cured, 29 showed symptom resolution, and 71 showed symptom improvement. In China, more than 90% of 74,187 patients who received 3M3F treatment, showed significant improvement. In contrast, a randomized, double-blind, placebo-controlled, multi-center clinical trial has shown that remdesivir is not very effective (7).


(2) 3M3F can reduce the financial burden of patients, especially in underdeveloped areas. The cost of COVID-19 treatment for eight western medicine candidates is estimated at $1.50 per day per person and from $0.30 to $31 for the full course of treatment (10–28 days) (8). The price of “Lung Cleaning and Detoxifying Decoction” is $5.91 per day per person and of “HuaShiBaidu Formula” and “Xuanfeibaidu Granule” is $3.41 and $3.07 per day per person, respectively. According to our survey in five China’s cities (see Table S1 of supplementary materials), the prices of these TCMs are quite stable. In contrast, the price of western medicine varies widely, ranging from $0.20 to $510 per course in countries that strictly hold down drug costs, such as India and Pakistan, but between $19 and $18,610 per course in the United States. In the past 2 weeks, COVID-19 has been alarmingly rampant in India, Africa, and South America, where the medical conditions are poor and population density is high. In some African countries, approximately 60% of the urban population lives in informal residences or slums, which increases vulnerability to COVID-19. If such economically backward areas adopt western medicines, they may greatly increase the risk of economic collapse and familial bankruptcy, which will subsequently lead to a series of other dire social consequences (9).

     

(3) The plants used for formulating 3M3F are common herbal medicines (10) with sufficient availability. These plants are cultivated in China, which is a responsible and a permanent member of the United Nations. Till date, the Chinese government has provided medical supplies to 127 countries and 4 international organizations in a humanitarian spirit. During the fight against this pandemic, China will ensure sufficient supply of 3M3F, and it is unlikely to raise prices following the surge in global demand. Moreover, it will not provide 3M3F to other nations under any political or economic conditions.


COVID-19 has already had a great impact on the global economy, which will gradually show its direct or indirect negative health effects in the future. According to the latest poll published by Gallup, one in seven American adults admitted that if they or a family member developed symptoms related to COVID-19, they would give up treatment because they were afraid they could not afford it. If COVID-19 caused an impact of the same strength in India and Africa as it did in the United States (>1.8 million infected as of June 1), it would be a disaster for humanity. Even if vaccines and specific treatments for COVID-19 are developed in the future (8, 11), it will create a large economic burden or these treatments might not be easily procured by some economically backward countries (12). If we lose any African county in the battle against this pandemic, we are destined for failure (12). At present, there are only 29 WHO-certified vaccine manufacturers globally. Even if they reach their maximum production efficiency, it is unlikely they will produce enough vaccines to meet the global demand of 7.7 billion people in a short period (Yu Wang, personal communication).

  

Currently, testing and quarantine are still the most important approaches to stop the spread of the virus. In a direct face-off with COVID-19, 3M3F should be valued by all countries because of its efficacy, price stability, and reasonable cost. Therefore, I call on all countries, including China, which is the largest producer of 3M3F and has successfully used it combating the pandemic and which took the initiative to create awareness regarding the use of 3M3F, to pay attention to its production, promotion, and application (5, 13).


REFERENCES AND NOTES


1.       N. Akpan, Why a coronavirus vaccine could take way longer than a year. Natl. Geogr. Mag. (2020), (available at https://www.nationalgeographic.com/science/2020/04/why-coronavirus-vaccine-could-take-way-longer-than-a-year/).

2.       S. Jiang, Don’t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees. Nature. 579, 321–321 (2020).

3.       Z. Jin et al., Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature (2020), doi:10.1038/s41586-020-2223-y.

4.       National Health Commission, “Diagnosis and Treatment Protocol of COVID-19 (Seventh Edition)” (Beijing, 2020), (available at https://www.who.int/docs/default-source/wpro---documents/countries/china/covid-19-briefing-nhc/1-clinical-protocols-for-the-diagnosis-and-treatment-of-covid-19-v7.pdf?sfvrsn=c6cbfba4_2).

5.       R. Li et al., Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacol. Res., 104761 (2020).

6.       E. Chorin et al., The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin. Nat. Med. (2020), doi:10.1038/s41591-020-0888-2.

7.       Y. Wang et al., Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet (2020), doi:10.1016/S0140-6736(20)31022-9.

8.      R. Service, Would-be coronavirus drugs are cheap to make. Science. (2020), doi:10.1126/science.abc1943.

9.       M. McKee, D. Stuckler, If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future. Nat. Med. (2020), doi:10.1038/s41591-020-0863-y.

10.     D. Zhang, K. Wu, X. Zhang, S. Deng, B. Peng, In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J. Integr. Med. 18, 152–158 (2020).

11.     J. Grein et al., Compassionate Use of Remdesivir for Patients with Severe Covid-19. N. Engl. J. Med. (2020), doi:10.1056/NEJMoa2007016.

12.     J. Nkengasong, Let Africa into the market for COVID-19 diagnostics. Nature. 580, 565–565 (2020).

13.     X. Cao, COVID-19: immunopathology and its implications for therapy. Nat. Rev. Immunol. (2020), doi:10.1038/s41577-020-0308-3.


Note: Yu Wang is a Professor at the Department of Earth System Science of Tsinghua University.


Acknowledgements

I am grateful to Hui Liu (Chinese Academy of Sciences), Jing Yang (Fudan University), Fudi Wang (Zhejiang University School of Medicine) and Dan Liu for their help in investigating the prices of "Three Medicines & Three Formulas" (3M3F) which is crucial for the writing of the manuscript.



https://blog.sciencenet.cn/blog-260340-1253058.html

上一篇:量子计算机如何重塑人类未来生活
下一篇:生态学是感性认识和思考时长的函数
收藏 IP: 114.248.135.*| 热度|

4 杨正瓴 李庆祥 宁利中 刘跃

该博文允许注册用户评论 请点击登录 评论 (0 个评论)

IP: 120.244.60.*   闁搞儳鍋涢ˇ锟� | 閻犙嶆嫹 閻犙嶆嫹 +1 [5]闁兼枼鈧偨浜eù纭锋嫹   2024-6-8 15:41
濡炶鍓欓崢鐘诲箑濠靛棙韬柡鍛壘閸曢箖鎯冮崟顒侇槯闁稿﹥鐟辩槐婵堟媼閵堝嫯绀嬪ù鐘崇墱濞堟垹鈧冻绠掗鈺呭嫉閳ь剚寰勮濞堟垿鏌嗗Δ浣告灓闁革负鍔嬬花顒€鈻介埄鍐╃畳闁稿繐鎳庨崹搴㈡交閹邦喗鏆忛柡浣规緲椤掔喖鏁嶅畝鍐惧敤閻庣懓鍟崹姘▔閸濆嫬鍓奸柣妞绘櫇閹﹦鈧冻缂氱粩鎾冀妞嬪海缈辩痪顓у枤濞堟垹绮旈幋婵愬妳闁靛棗鍊诲ú浼村礈瀹ュ洦鏅搁柟顑跨椤掔喖鎯冮崟顓犲煛缂佸本婀圭弧鍐椤厼顦查弶鈺傜懄閻楅亶鎯冮崟顐e瘻閻忓浚鍓ㄧ槐婵堜焊鏉堛劍笑鐎垫澘鐗嗛ˇ鍧楀储閻旂儤鍊為柛娆樹海閸忔﹢鎮介妸銉π€瑰摜顥愰鈺冩嫚鏉堝墽绀夋鐐跺煐閻ュ懘鎳楁禒瀣у亾濮樺磭绠栭柡浣规緲椤掔喓鍒掗崜褉鈧﹢宕烽幏灞烩偓鍐╂綇娣囨墎鍋撻崒娑氭Х濠碘€冲€圭槐銊╁即閸喗瀚叉繝鏇熸煥鐎垫煡鏁嶇仦鑺ョ殤闁哄秷顫夊﹢浼村籍閻樺磭銆婇柣鈧妼閸ら亶寮悧鍫熼檷閻炴稏鍔忛幓顏堝Υ閿燂拷
闁搞儳鍋涢ˇ锟�  闁挎冻鎷� 闁哄嫷鍨冲▓鎴︽嚄闄囬埀顑跨缁椻偓闁挎稑鏈崹婊勭▕閻斿墎顏遍柣鈺冾棎椤骸顕ュΔ浣哄窛闁告牗鐗滈弫鎾绘偋閳轰緡鍔呮慨锝嗘缁舵繂鈻庨悩闈涚箒闁轰焦婢橀鐔兼儍閸曨偄鏁堕悗鐧告嫹
2024-6-12 10:111 婵°倗銆嬬槐娆撳炊閻愬樊妲绘俊銈夋?鐎靛矂鏁嶉敓锟� 閻犙嶆嫹 閻犙嶆嫹 +1 | 闁搞儳鍋涢ˇ锟�
IP: 183.218.205.*   闁搞儳鍋涢ˇ锟� | 閻犙嶆嫹 閻犙嶆嫹 +1 [4]闁告帗岣块~鍛潖閿燂拷   2021-5-15 16:19
闁哄娴囬崵褔鎮介悢绯曞亾娴e壊鍔呴柨娑虫嫹
闁搞儳鍋涢ˇ锟�  闁挎冻鎷� 濠㈣埖淇洪梼鍧楀礆濡簱鍋撴担鍝ョ憥闁挎冻鎷�
2021-5-15 19:141 婵°倗銆嬬槐娆撳炊閻愬樊妲绘俊銈夋?鐎靛矂鏁嶉敓锟� 閻犙嶆嫹 閻犙嶆嫹 +1 | 闁搞儳鍋涢ˇ锟�
IP: 223.68.90.*   闁搞儳鍋涢ˇ锟� | 閻犙嶆嫹 閻犙嶆嫹 +1 [3]闂佺晫鍠庨悾楣冩嚄閿燂拷   2021-1-3 13:14
闁告鐭€靛矂鎯冮崟顔剧濞戞搩浜滈崣鏇烆嚕韫囨搩鍤犻柟纰樺亾闁哄牆顦鐔虹矓閹达箑鍘撮柛鈺冨劋濠€浼存焻閸屾粍鏆� 闁挎稑鑻ぐ褔寮伴娑樹紟閺夆晠顣︾粭鍌炲矗椤栨瑤绨伴柛瀣煯缁ㄦ椽鏌呴崒姘卞畨闁诡儸鍛暠濞e浂鍠楅弫濂告晬鐏炲墽妲峰┑鈥冲€告晶鐘绘嚀閸涙壆绠烽柛娆樺灟娴滄帡寮伴婊勬櫢婵炴彃顭峰Σ鍕储閸℃劏鍋撴担绋垮潑闁告瑨灏~鍥┾偓鐢靛枑閸ㄣ劑寮崶鈺佺泙闁活厹鍎撮惁鎴犵矓椤栨粎鏌堝☉鏂款儑鐞氼偊鎯冮崟鍓佺闁告艾姘﹂埀顒€鎳撶换鏇㈠矗椤栨瑤绨伴柡鍕靛灦閺嗛亶寮崼鏇燂紵闂傚牊鐟ョ缓楣冨箑濠靛ň鍋撻崘锔瑰亾娴gǹ鍐€濠㈣泛绉甸埀顒佺箚閳ь剙鍟ㄩ埀顑跨劍缁讳焦鎯旈敂瑙e亾濠靛ň鍋撻崘锔瑰亾娴h棄绐涢柣銈嗗灦鐎氬綊姊婚鑲╃闁诡剚绻嗛埀顒€鍟ㄩ埀顑跨椤﹁法鎲撮幒鎴濐唺闁诡剚绻嗛埀顒€鍟╃粻锝囩尵閼姐倖鐣遍柕鍡嫹
闁搞儳鍋涢ˇ锟�  闁挎冻鎷� 闁告繂鐗嗛幖閬嶆晬鐏炵瓔妯嬮悹瀣ㄥ灲閹告捇鎳撴担鍝ョ憥閻炴稏鍎遍崢鏍晬鐏炵晫鍙戦柡鍫濐樀娴滈箖鎮堕崱顓犵<
2021-1-3 13:321 婵°倗銆嬬槐娆撳炊閻愬樊妲绘俊銈夋?鐎靛矂鏁嶉敓锟� 閻犙嶆嫹 閻犙嶆嫹 +1 | 闁搞儳鍋涢ˇ锟�
IP: 113.47.82.*   闁搞儳鍋涢ˇ锟� | 閻犙嶆嫹 閻犙嶆嫹 +1 [2]闁兼枼鈧偨浜eù纭锋嫹   2021-1-3 09:01
婵炲备鍓濆﹢渚€鎯囩€n偄娅�
闁搞儳鍋涢ˇ锟�  闁挎冻鎷� 濞戞挸绨肩花鈺呮嚀閸涱噮鍔€闁烩晝枪閸櫻囧Υ閿燂拷
2021-1-3 09:391 婵°倗銆嬬槐娆撳炊閻愬樊妲绘俊銈夋?鐎靛矂鏁嶉敓锟� 閻犙嶆嫹 閻犙嶆嫹 +1 | 闁搞儳鍋涢ˇ锟�
IP: 223.89.150.*   闁搞儳鍋涢ˇ锟� | 閻犙嶆嫹 閻犙嶆嫹 +1 [1]濞寸媴绲惧妤冣偓鐧告嫹   2021-1-3 07:55
  
闁搞儳鍋涢ˇ锟�  闁挎冻鎷�   
2021-1-3 09:391 婵°倗銆嬬槐娆撳炊閻愬樊妲绘俊銈夋?鐎靛矂鏁嶉敓锟� 閻犙嶆嫹 閻犙嶆嫹 +1 | 闁搞儳鍋涢ˇ锟�

1/1 | 闁诡剚妲掗锟�:5 | 濡絾鐗犻妴锟� | 濞戞挸锕g粩瀛樸亜閿燂拷 | 濞戞挸顑勭粩瀛樸亜閿燂拷 | 闁哄牜鍋婇妴锟� | 閻犲搫鐤囧ù锟�

Archiver|手机版|科学网 ( 京ICP备07017567号-12 )

GMT+8, 2025-2-3 12:39

Powered by ScienceNet.cn

Copyright © 2007-2025 中国科学报社

返回顶部